CLINICAL_TRIALS
trial_result
· 2019-06-03
Clinical Trial Update: A Study for G1b CHC Patients With CKD-3 Treated With Grazoprevir Plus Elbasvir [Phase 4]
Summary
Phase 4 trial update for Grazoprevir plus Elbasvir in G1b chronic hepatitis C patients with CKD stage 3; completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kyushu University | Conditions: Hepatitis C Viral, Chronic Kidney Disease stage3 | Phase 4 | Status: COMPLETED | Results posted: 2019-06-03